Brief: Polyphor Gets USD 2.3 Mln Award From Carb-X To Support Development Of New Class Of Antibiotics
Dec 11 (Reuters) - POLYPHOR AG POLN.S :
* RECEIVES AN ADDITIONAL USD 2.3 MILLION AWARD FROM CARB-X
TO
SUPPORT ONGOING DEVELOPMENT OF A NEW CLASS OF ANTIBIOTICS
TARGETING MULTI-DRUG RESISTANT GRAM-NEGATIVE PATHOGENS
* MAY ALSO RECEIVE UP TO USD 13 MILLION IN FUTURE OPTION
STAGES
THAT COULD TAKE PROGRAM THROUGH A FIRST-IN-HUMAN PROGRAM IF
CERTAIN PROJECT MILESTONES ARE MET
Source text for Eikon: ID:nEQ27MsFta
Further company coverage: POLN.S
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Spexis AG
See all newsBrief: Spexis AG: Expects Audit Of 2023 Financials Will Not Be Completed By 31 July 2024
Brief: Spexis Launches Appeal Against Six Exchange Regulation Decision To Suspend Trading Of Its Shares.
Brief: Spexis AG- Audit Costs Have Not Been Approved Yet And Further Extension May Be Required
Brief: Spexis Announces CFO Hernan Levett Has Decided To Pursue New Career Outside Company
Brief: Spexis: Total Loss Of CHF 3.9 Mln In H1 2023